Hudson Bay Capital Management
IMMX icon

Hudson Bay Capital Management’s Immix Biopharma IMMX Stock Holding History

Hudson Bay Capital Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$578K Buy
63,501
+29,852
+89% +$219K ﹤0.01% 956
2025
Q4 		$176K Buy
+33,649
New +$138K ﹤0.01% 981

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Hudson Bay Capital Management's IMMX Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Immix Biopharma (IMMX) stake by 89% in Q1 2026, buying an estimated $219K and bringing the position to 63,501 shares worth $578K. The position accounts for ﹤0.01% of the portfolio, ranked #956.

Hudson Bay Capital Management first reported a position in IMMX in Q4 2025 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Hudson Bay Capital Management held 63,501 shares of Immix Biopharma worth $578K as of Q1 2026.
  • Hudson Bay Capital Management bought 29,852 Immix Biopharma shares in Q1 2026, an estimated $219K.
  • Immix Biopharma made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #956 holding.
  • Hudson Bay Capital Management first reported a position in Immix Biopharma in Q4 2025 and has held it in 2 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.